Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Kersting

Showing results (11-20 of 81) with videos related to

Pageof 9
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|April 24, 2024
Correction to: Highlights of the 36th EANM Annual Congress 2023, from hometown Vienna, Austria: "A SYMPHONY OF SCIENCE"David Kersting, Silvia Morbelli, Sophie E M Veldhuijzen van Zanten, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 3, 2024
Highlights of the 36th EANM Annual Congress 2023, from hometown Vienna, Austria: "A SYMPHONY OF SCIENCE"David Kersting, Silvia Morbelli, Sophie E M Veldhuijzen van Zanten, et al.
International Journal of Molecular Sciences|April 12, 2022
Shining Damaged Hearts: Immunotherapy-Related Cardiotoxicity in the Spotlight of Nuclear CardiologyDavid Kersting, Stephan Settelmeier, Ilektra-Antonia Mavroeidi, et al.
Frontiers in Endocrinology|April 30, 2025
Impact of functionality and grading on survival in pancreatic neuroendocrine tumor patients receiving peptide receptor radionuclide therapyAnnie Mathew, David Kersting, Wolfgang P Fendler, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 28, 2026
Post-hoc analysis of adverse events during the EPOCH trial: reconsidering dosimetryMarnix Lam, David Kersting, William Harris, et al.
European Journal of Hybrid Imaging|December 20, 2021
Atypical bilateral ventilation/perfusion mismatches in an asymptomatic patient suffering from metastatic thyroid cancerDavid Kersting, Christoph Rischpler, Till Plönes, et al.
Physics in Medicine and Biology|June 26, 2024
PET quantification performance of the oversize-volume-of-interest approach in the context of tumour dosimetry in radionuclide therapy planningNoah Hammersen, Walter Jentzen, Florian Stawitzki, et al.
Oncology Research and Treatment|November 24, 2021
The Future Role of PET Imaging in Metastatic Breast CancerKim M Pabst, Thomas Decker, David Kersting, et al.
AJR. American Journal of Roentgenology|September 27, 2023
Imaging of Cardiac Fibrosis: An Update, From the <i>AJR</i> Special Series on Imaging of FibrosisGauri R Karur, Ashish Aneja, Jadranka Stojanovska, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 2, 2023
Molecular Imaging Biomarkers in Cardiooncology: A View on Established Technologies and Future PerspectivesDavid Kersting, Ilektra-Antonia Mavroeidi, Stephan Settelmeier, et al.
Pageof 9

Showing results (11-20 of 81) with videos related to

Sort By:
Pageof 9
European Journal of Nuclear Medicine and Molecular Imaging|April 24, 2024
Correction to: Highlights of the 36th EANM Annual Congress 2023, from hometown Vienna, Austria: "A SYMPHONY OF SCIENCE"David Kersting, Silvia Morbelli, Sophie E M Veldhuijzen van Zanten, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 3, 2024
Highlights of the 36th EANM Annual Congress 2023, from hometown Vienna, Austria: "A SYMPHONY OF SCIENCE"David Kersting, Silvia Morbelli, Sophie E M Veldhuijzen van Zanten, et al.
International Journal of Molecular Sciences|April 12, 2022
Shining Damaged Hearts: Immunotherapy-Related Cardiotoxicity in the Spotlight of Nuclear CardiologyDavid Kersting, Stephan Settelmeier, Ilektra-Antonia Mavroeidi, et al.
Frontiers in Endocrinology|April 30, 2025
Impact of functionality and grading on survival in pancreatic neuroendocrine tumor patients receiving peptide receptor radionuclide therapyAnnie Mathew, David Kersting, Wolfgang P Fendler, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 28, 2026
Post-hoc analysis of adverse events during the EPOCH trial: reconsidering dosimetryMarnix Lam, David Kersting, William Harris, et al.
European Journal of Hybrid Imaging|December 20, 2021
Atypical bilateral ventilation/perfusion mismatches in an asymptomatic patient suffering from metastatic thyroid cancerDavid Kersting, Christoph Rischpler, Till Plönes, et al.
Physics in Medicine and Biology|June 26, 2024
PET quantification performance of the oversize-volume-of-interest approach in the context of tumour dosimetry in radionuclide therapy planningNoah Hammersen, Walter Jentzen, Florian Stawitzki, et al.
Oncology Research and Treatment|November 24, 2021
The Future Role of PET Imaging in Metastatic Breast CancerKim M Pabst, Thomas Decker, David Kersting, et al.
AJR. American Journal of Roentgenology|September 27, 2023
Imaging of Cardiac Fibrosis: An Update, From the <i>AJR</i> Special Series on Imaging of FibrosisGauri R Karur, Ashish Aneja, Jadranka Stojanovska, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 2, 2023
Molecular Imaging Biomarkers in Cardiooncology: A View on Established Technologies and Future PerspectivesDavid Kersting, Ilektra-Antonia Mavroeidi, Stephan Settelmeier, et al.
Pageof 9